Novartis [clinicaltrials_resource:620b39a6ec4f160cc195e448be24ea89]
An Evaluation of the Efficacy and Safety of Tegaserod 6 mg Bid Given Orally to Chinese Patients With Chronic Constipation [clinicaltrials:NCT00139568]Assessment of the Effect of Tegaserod (2 mg Tid and 6 mg Tid) on Dyspeptic Symptoms in Diabetic Patients With Symptoms of Diabetic Gastropathy [clinicaltrials:NCT00142974]Efficacy, Safety and Tolerability of Tegaserod in Patients With Chronic Constipation [clinicaltrials:NCT00149877]
location [clinicaltrials_vocabulary:location]
Novartis [clinicaltrials_resource:620b39a6ec4f160cc195e448be24ea89]
Bio2RDF identifier
620b39a6ec4f160cc195e448be24ea89
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:620b39a6ec4f160cc195e448be24ea89
address [clinicaltrials_vocabulary:address]
identifier
clinicaltrials_resource:620b39a6ec4f160cc195e448be24ea89
title
Novartis
@en
type
label
Novartis [clinicaltrials_resource:620b39a6ec4f160cc195e448be24ea89]
@en